Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

Overview of attention for article published in International Journal of Hematology, December 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#10 of 1,533)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

policy: 1 policy source
twitter: 39 X users

patent: 12 patents

Citations

dimensions_citation: 93 Dimensions

Readers on

mendeley: 183 Mendeley

Summary Policy documents X Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of…

Grant US-11806365-B2

United States of America

Methods and compositions for dosing in adoptive cell therapy

Grant US-11633426-B2

United States of America

TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS

Grant EP-4019041-B1

European Patent Office

Compositions and methods for targeting CD33-expressing cancers

Grant US-11479606-B2

United States of America

Kappa myeloma antigen chimeric antigen receptors and uses thereof

Grant US-11305011-B2

United States of America

Chimeric antigen receptors

Grant US-11130820-B2

United States of America

Antibody

Grant US-10988540-B2

United States of America

Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of…

Grant US-10967005-B2

United States of America

TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS

Grant EP-2872171-B1

European Patent Office

Antibody

Grant US-10654931-B2

United States of America

CHIMERIC ANTIGEN RECEPTORS (CAR)-EXPRESSING CELLS AND COMBINATION TREATMENT FOR…

Application WO-2020007593-A1

World Intellectual Property Organisation (WIPO)

ANTIBODY

Application EP-3336184-A4

European Patent Office